BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 11689794)

  • 1. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
    Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
    Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
    Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
    Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
    Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In what case can we abbreviate mediastinal lymph nodes dissection of peripheral small-sized lung cancer?].
    Yamane Y; Shimada K; Ishida I
    Kyobu Geka; 2004 Jan; 57(1):61-6. PubMed ID: 14733101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance].
    Chen Z; Lu X; Huang R
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):69-71. PubMed ID: 10743062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer.
    Nakagawa T; Okumura N; Miyoshi K; Matsuoka T; Kameyama K
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):635-9. PubMed ID: 16126398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
    Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer.
    Ito M; Minamiya Y; Kawai H; Saito S; Saito H; Imai K; Ogawa J
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):753-8. PubMed ID: 16153924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of pathological stage III and IV in non-small cell lung cancer with peripheral tumor of 3 cm or less in diameter].
    Kikuchi K; Kase K; Sensaki K; Masuda H; Takagi K; Ogata T; Tanaka S
    Kyobu Geka; 1991 Jan; 44(1):51-5. PubMed ID: 1645421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer.
    Zingg U; Montani M; Busch M; Metzger U; Went P; Oertli D
    Eur J Surg Oncol; 2009 Jun; 35(6):593-9. PubMed ID: 19121916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy for surgical treatment for small peripheral carcinoma of the lung especially on systemic nodal dissection].
    Watanabe A; Osawa H; Obama T; Watanabe T; Mawatari T; Ichimiya Y; Takahashi N; Abe T; Sato M; Abe S; Kusajima K
    Kyobu Geka; 2004 Jan; 57(1):20-4. PubMed ID: 14733094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.